Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Estrogen Receptor Antagonist 7 (Compound 13) is a potent antagonist of estrogen receptors (ER), demonstrating antiproliferative effects against breast and ovarian cancer cells, along with anticancer and anti-uterotrophic activities [1].

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 25 mg | $1,520 | 10-14 weeks | |
| 50 mg | $1,980 | 10-14 weeks | |
| 100 mg | $2,500 | 10-14 weeks | 
| Description | Estrogen Receptor Antagonist 7 (Compound 13) is a potent antagonist of estrogen receptors (ER), demonstrating antiproliferative effects against breast and ovarian cancer cells, along with anticancer and anti-uterotrophic activities [1].  | 
| In vitro | Estrogen receptor antagonist 7 (compound 13) exhibits antiproliferative activity against MCF-7, T-47D, and SKOV-3 cell lines with IC50 values of 7.2 μM, 11.71 μM, and 29.8 μM, respectively [1].  | 
| Molecular Weight | 399.4 | 
| Formula | C23H17N3O4 | 
| Cas No. | 2889371-04-2 | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.